nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—TSPO—hindlimb—skin cancer	0.0288	0.158	CbGeAlD
Lorazepam—Instillation site pain—Imiquimod—skin cancer	0.0279	0.0342	CcSEcCtD
Lorazepam—Unsteadiness—Fluorouracil—skin cancer	0.025	0.0307	CcSEcCtD
Lorazepam—TSPO—appendage—skin cancer	0.0247	0.135	CbGeAlD
Lorazepam—Application site pain—Imiquimod—skin cancer	0.0207	0.0253	CcSEcCtD
Lorazepam—Brain oedema—Temozolomide—skin cancer	0.0191	0.0234	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Vismodegib—skin cancer	0.0173	0.0211	CcSEcCtD
Lorazepam—Paralysis—Vemurafenib—skin cancer	0.0154	0.0188	CcSEcCtD
Lorazepam—TSPO—hair follicle—skin cancer	0.0147	0.0803	CbGeAlD
Lorazepam—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.0144	0.0176	CcSEcCtD
Lorazepam—UGT2B15—female reproductive system—skin cancer	0.0139	0.076	CbGeAlD
Lorazepam—TSPO—blood vessel—skin cancer	0.0138	0.0753	CbGeAlD
Lorazepam—Hyponatraemia—Vismodegib—skin cancer	0.0126	0.0154	CcSEcCtD
Lorazepam—Application site pain—Fluorouracil—skin cancer	0.0114	0.014	CcSEcCtD
Lorazepam—Slurred speech—Fluorouracil—skin cancer	0.0112	0.0138	CcSEcCtD
Lorazepam—TSPO—nipple—skin cancer	0.00996	0.0544	CbGeAlD
Lorazepam—TSPO—neck—skin cancer	0.00985	0.0539	CbGeAlD
Lorazepam—Balance disorder—Fluorouracil—skin cancer	0.00919	0.0113	CcSEcCtD
Lorazepam—Pericardial effusion—Docetaxel—skin cancer	0.00884	0.0108	CcSEcCtD
Lorazepam—Gastrointestinal symptom NOS—Fluorouracil—skin cancer	0.00855	0.0105	CcSEcCtD
Lorazepam—Pulmonary oedema—Imiquimod—skin cancer	0.0081	0.00992	CcSEcCtD
Lorazepam—Coagulopathy—Dactinomycin—skin cancer	0.00775	0.00948	CcSEcCtD
Lorazepam—Alopecia—Vismodegib—skin cancer	0.00767	0.00938	CcSEcCtD
Lorazepam—Aggression—Bleomycin—skin cancer	0.00736	0.00901	CcSEcCtD
Lorazepam—Extrapyramidal disorder—Temozolomide—skin cancer	0.00724	0.00887	CcSEcCtD
Lorazepam—TSPO—connective tissue—skin cancer	0.00706	0.0386	CbGeAlD
Lorazepam—Coagulopathy—Temozolomide—skin cancer	0.00701	0.00858	CcSEcCtD
Lorazepam—Memory impairment—Temozolomide—skin cancer	0.00695	0.00851	CcSEcCtD
Lorazepam—Lethargy—Imiquimod—skin cancer	0.00674	0.00825	CcSEcCtD
Lorazepam—TSPO—epithelium—skin cancer	0.00671	0.0367	CbGeAlD
Lorazepam—Liver injury—Temozolomide—skin cancer	0.00648	0.00793	CcSEcCtD
Lorazepam—GABRB3—connective tissue—skin cancer	0.00641	0.0351	CbGeAlD
Lorazepam—TSPO—skin of body—skin cancer	0.00638	0.0349	CbGeAlD
Lorazepam—Cystitis noninfective—Bleomycin—skin cancer	0.00632	0.00773	CcSEcCtD
Lorazepam—Irritability—Imiquimod—skin cancer	0.00631	0.00772	CcSEcCtD
Lorazepam—Cystitis—Bleomycin—skin cancer	0.00624	0.00764	CcSEcCtD
Lorazepam—Bladder pain—Bleomycin—skin cancer	0.00585	0.00716	CcSEcCtD
Lorazepam—TSPO—mammalian vulva—skin cancer	0.00582	0.0318	CbGeAlD
Lorazepam—Respiratory failure—Temozolomide—skin cancer	0.00555	0.0068	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Temozolomide—skin cancer	0.00546	0.00668	CcSEcCtD
Lorazepam—Pancytopenia—Imiquimod—skin cancer	0.00542	0.00664	CcSEcCtD
Lorazepam—Redness—Docetaxel—skin cancer	0.00537	0.00658	CcSEcCtD
Lorazepam—Leukocytosis—Fluorouracil—skin cancer	0.00535	0.00655	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vismodegib—skin cancer	0.00532	0.00651	CcSEcCtD
Lorazepam—Fatigue—Vismodegib—skin cancer	0.00531	0.0065	CcSEcCtD
Lorazepam—Dysarthria—Fluorouracil—skin cancer	0.00531	0.0065	CcSEcCtD
Lorazepam—Pain—Vismodegib—skin cancer	0.00527	0.00645	CcSEcCtD
Lorazepam—Constipation—Vismodegib—skin cancer	0.00527	0.00645	CcSEcCtD
Lorazepam—Urinary incontinence—Temozolomide—skin cancer	0.00527	0.00645	CcSEcCtD
Lorazepam—Depressed level of consciousness—Temozolomide—skin cancer	0.00527	0.00645	CcSEcCtD
Lorazepam—Erectile dysfunction—Imiquimod—skin cancer	0.00526	0.00644	CcSEcCtD
Lorazepam—Disorientation—Bleomycin—skin cancer	0.00525	0.00642	CcSEcCtD
Lorazepam—TSPO—lymphoid tissue—skin cancer	0.00516	0.0282	CbGeAlD
Lorazepam—TSPO—female reproductive system—skin cancer	0.00498	0.0272	CbGeAlD
Lorazepam—GABRG2—head—skin cancer	0.00492	0.0269	CbGeAlD
Lorazepam—Chills—Vemurafenib—skin cancer	0.00481	0.00589	CcSEcCtD
Lorazepam—Alopecia—Vemurafenib—skin cancer	0.00474	0.0058	CcSEcCtD
Lorazepam—Mental disability—Temozolomide—skin cancer	0.00473	0.00579	CcSEcCtD
Lorazepam—Erythema—Vemurafenib—skin cancer	0.00467	0.00571	CcSEcCtD
Lorazepam—Coma—Fluorouracil—skin cancer	0.00459	0.00562	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.00455	0.00557	CcSEcCtD
Lorazepam—GABRB3—female reproductive system—skin cancer	0.00452	0.0247	CbGeAlD
Lorazepam—Lethargy—Dactinomycin—skin cancer	0.00447	0.00547	CcSEcCtD
Lorazepam—Asthenia—Vismodegib—skin cancer	0.00442	0.00541	CcSEcCtD
Lorazepam—Visual impairment—Imiquimod—skin cancer	0.00441	0.00539	CcSEcCtD
Lorazepam—GABRA1—head—skin cancer	0.00434	0.0237	CbGeAlD
Lorazepam—Euphoric mood—Fluorouracil—skin cancer	0.00432	0.00529	CcSEcCtD
Lorazepam—Amnesia—Temozolomide—skin cancer	0.00421	0.00516	CcSEcCtD
Lorazepam—TSPO—head—skin cancer	0.00416	0.0227	CbGeAlD
Lorazepam—Chills—Imiquimod—skin cancer	0.0041	0.00502	CcSEcCtD
Lorazepam—Arrhythmia—Imiquimod—skin cancer	0.00408	0.005	CcSEcCtD
Lorazepam—Disorientation—Fluorouracil—skin cancer	0.00408	0.00499	CcSEcCtD
Lorazepam—Liver function test abnormal—Dactinomycin—skin cancer	0.00404	0.00495	CcSEcCtD
Lorazepam—Alopecia—Imiquimod—skin cancer	0.00404	0.00494	CcSEcCtD
Lorazepam—Erythema—Imiquimod—skin cancer	0.00398	0.00487	CcSEcCtD
Lorazepam—Diplopia—Temozolomide—skin cancer	0.00396	0.00485	CcSEcCtD
Lorazepam—Vomiting—Vismodegib—skin cancer	0.00392	0.0048	CcSEcCtD
Lorazepam—Rash—Vismodegib—skin cancer	0.00389	0.00476	CcSEcCtD
Lorazepam—Amnesia—Fluorouracil—skin cancer	0.00388	0.00475	CcSEcCtD
Lorazepam—Dermatitis—Vismodegib—skin cancer	0.00388	0.00475	CcSEcCtD
Lorazepam—Pancytopenia—Bleomycin—skin cancer	0.00385	0.00472	CcSEcCtD
Lorazepam—Infection—Vemurafenib—skin cancer	0.00378	0.00463	CcSEcCtD
Lorazepam—GABRB3—head—skin cancer	0.00378	0.0207	CbGeAlD
Lorazepam—Ataxia—Temozolomide—skin cancer	0.00372	0.00456	CcSEcCtD
Lorazepam—Lethargy—Fluorouracil—skin cancer	0.00372	0.00456	CcSEcCtD
Lorazepam—Respiratory failure—Docetaxel—skin cancer	0.00369	0.00452	CcSEcCtD
Lorazepam—Nausea—Vismodegib—skin cancer	0.00366	0.00448	CcSEcCtD
Lorazepam—Agitation—Imiquimod—skin cancer	0.00366	0.00448	CcSEcCtD
Lorazepam—Osteoarthritis—Fluorouracil—skin cancer	0.00365	0.00447	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00365	0.00447	CcSEcCtD
Lorazepam—Hepatocellular injury—Docetaxel—skin cancer	0.00363	0.00444	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00363	0.00444	CcSEcCtD
Lorazepam—Injection site reaction—Docetaxel—skin cancer	0.00361	0.00441	CcSEcCtD
Lorazepam—Pancytopenia—Dactinomycin—skin cancer	0.00359	0.0044	CcSEcCtD
Lorazepam—Hypotension—Vemurafenib—skin cancer	0.00356	0.00435	CcSEcCtD
Lorazepam—Irritability—Fluorouracil—skin cancer	0.00348	0.00426	CcSEcCtD
Lorazepam—Cardiac arrest—Fluorouracil—skin cancer	0.00347	0.00425	CcSEcCtD
Lorazepam—Convulsion—Imiquimod—skin cancer	0.00345	0.00422	CcSEcCtD
Lorazepam—Hypertension—Imiquimod—skin cancer	0.00344	0.0042	CcSEcCtD
Lorazepam—Ataxia—Fluorouracil—skin cancer	0.00343	0.0042	CcSEcCtD
Lorazepam—Dry mouth—Imiquimod—skin cancer	0.00331	0.00405	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00329	0.00402	CcSEcCtD
Lorazepam—Fatigue—Vemurafenib—skin cancer	0.00328	0.00402	CcSEcCtD
Lorazepam—Constipation—Vemurafenib—skin cancer	0.00326	0.00399	CcSEcCtD
Lorazepam—Pancytopenia—Temozolomide—skin cancer	0.00325	0.00398	CcSEcCtD
Lorazepam—Pulmonary oedema—Docetaxel—skin cancer	0.00323	0.00395	CcSEcCtD
Lorazepam—Infection—Imiquimod—skin cancer	0.00323	0.00395	CcSEcCtD
Lorazepam—Tachycardia—Imiquimod—skin cancer	0.00317	0.00388	CcSEcCtD
Lorazepam—Erectile dysfunction—Temozolomide—skin cancer	0.00315	0.00386	CcSEcCtD
Lorazepam—Agranulocytosis—Dactinomycin—skin cancer	0.00315	0.00385	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00303	0.00371	CcSEcCtD
Lorazepam—Pancytopenia—Fluorouracil—skin cancer	0.00299	0.00366	CcSEcCtD
Lorazepam—TSPO—lymph node—skin cancer	0.00291	0.0159	CbGeAlD
Lorazepam—Chills—Bleomycin—skin cancer	0.00291	0.00357	CcSEcCtD
Lorazepam—Somnolence—Imiquimod—skin cancer	0.00289	0.00353	CcSEcCtD
Lorazepam—Alopecia—Bleomycin—skin cancer	0.00287	0.00351	CcSEcCtD
Lorazepam—Erythema—Bleomycin—skin cancer	0.00283	0.00346	CcSEcCtD
Lorazepam—Hypersensitivity—Vemurafenib—skin cancer	0.00281	0.00343	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Imiquimod—skin cancer	0.0028	0.00343	CcSEcCtD
Lorazepam—Fatigue—Imiquimod—skin cancer	0.0028	0.00343	CcSEcCtD
Lorazepam—Visual disturbance—Docetaxel—skin cancer	0.00278	0.0034	CcSEcCtD
Lorazepam—Pain—Imiquimod—skin cancer	0.00278	0.0034	CcSEcCtD
Lorazepam—Asthenia—Vemurafenib—skin cancer	0.00273	0.00334	CcSEcCtD
Lorazepam—Hallucination—Temozolomide—skin cancer	0.00273	0.00334	CcSEcCtD
Lorazepam—Chills—Dactinomycin—skin cancer	0.00272	0.00333	CcSEcCtD
Lorazepam—Lethargy—Docetaxel—skin cancer	0.00269	0.00329	CcSEcCtD
Lorazepam—Alopecia—Dactinomycin—skin cancer	0.00268	0.00328	CcSEcCtD
Lorazepam—Feeling abnormal—Imiquimod—skin cancer	0.00268	0.00328	CcSEcCtD
Lorazepam—Hyponatraemia—Docetaxel—skin cancer	0.00264	0.00324	CcSEcCtD
Lorazepam—Visual impairment—Temozolomide—skin cancer	0.00264	0.00323	CcSEcCtD
Lorazepam—Erythema—Dactinomycin—skin cancer	0.00264	0.00323	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00263	0.00322	CcSEcCtD
Lorazepam—Agranulocytosis—Fluorouracil—skin cancer	0.00262	0.00321	CcSEcCtD
Lorazepam—Dizziness—Vemurafenib—skin cancer	0.00252	0.00308	CcSEcCtD
Lorazepam—Ataxia—Docetaxel—skin cancer	0.00248	0.00303	CcSEcCtD
Lorazepam—Chills—Temozolomide—skin cancer	0.00246	0.00301	CcSEcCtD
Lorazepam—Liver function test abnormal—Docetaxel—skin cancer	0.00243	0.00298	CcSEcCtD
Lorazepam—Vomiting—Vemurafenib—skin cancer	0.00242	0.00296	CcSEcCtD
Lorazepam—Alopecia—Temozolomide—skin cancer	0.00242	0.00296	CcSEcCtD
Lorazepam—Rash—Vemurafenib—skin cancer	0.0024	0.00294	CcSEcCtD
Lorazepam—Dermatitis—Vemurafenib—skin cancer	0.0024	0.00294	CcSEcCtD
Lorazepam—Hypersensitivity—Imiquimod—skin cancer	0.00239	0.00293	CcSEcCtD
Lorazepam—Headache—Vemurafenib—skin cancer	0.00239	0.00292	CcSEcCtD
Lorazepam—Erythema—Temozolomide—skin cancer	0.00238	0.00292	CcSEcCtD
Lorazepam—Asthenia—Imiquimod—skin cancer	0.00233	0.00285	CcSEcCtD
Lorazepam—Confusional state—Bleomycin—skin cancer	0.00233	0.00285	CcSEcCtD
Lorazepam—Infection—Bleomycin—skin cancer	0.00229	0.00281	CcSEcCtD
Lorazepam—Nausea—Vemurafenib—skin cancer	0.00226	0.00277	CcSEcCtD
Lorazepam—Thrombocytopenia—Bleomycin—skin cancer	0.00226	0.00276	CcSEcCtD
Lorazepam—Arrhythmia—Fluorouracil—skin cancer	0.00225	0.00276	CcSEcCtD
Lorazepam—Vision blurred—Temozolomide—skin cancer	0.00225	0.00275	CcSEcCtD
Lorazepam—Tremor—Temozolomide—skin cancer	0.00223	0.00273	CcSEcCtD
Lorazepam—Alopecia—Fluorouracil—skin cancer	0.00223	0.00273	CcSEcCtD
Lorazepam—Erythema—Fluorouracil—skin cancer	0.0022	0.00269	CcSEcCtD
Lorazepam—Agitation—Temozolomide—skin cancer	0.00219	0.00268	CcSEcCtD
Lorazepam—Pancytopenia—Docetaxel—skin cancer	0.00216	0.00265	CcSEcCtD
Lorazepam—Hypotension—Bleomycin—skin cancer	0.00216	0.00264	CcSEcCtD
Lorazepam—Dizziness—Imiquimod—skin cancer	0.00215	0.00263	CcSEcCtD
Lorazepam—Vertigo—Temozolomide—skin cancer	0.00214	0.00262	CcSEcCtD
Lorazepam—Infection—Dactinomycin—skin cancer	0.00214	0.00262	CcSEcCtD
Lorazepam—Thrombocytopenia—Dactinomycin—skin cancer	0.00211	0.00258	CcSEcCtD
Lorazepam—Vision blurred—Fluorouracil—skin cancer	0.00207	0.00253	CcSEcCtD
Lorazepam—Convulsion—Temozolomide—skin cancer	0.00207	0.00253	CcSEcCtD
Lorazepam—Vomiting—Imiquimod—skin cancer	0.00206	0.00253	CcSEcCtD
Lorazepam—Hypertension—Temozolomide—skin cancer	0.00206	0.00252	CcSEcCtD
Lorazepam—Rash—Imiquimod—skin cancer	0.00205	0.00251	CcSEcCtD
Lorazepam—Dermatitis—Imiquimod—skin cancer	0.00205	0.0025	CcSEcCtD
Lorazepam—Headache—Imiquimod—skin cancer	0.00203	0.00249	CcSEcCtD
Lorazepam—Dry mouth—Temozolomide—skin cancer	0.00199	0.00243	CcSEcCtD
Lorazepam—Jaundice—Docetaxel—skin cancer	0.00198	0.00242	CcSEcCtD
Lorazepam—Pain—Bleomycin—skin cancer	0.00197	0.00241	CcSEcCtD
Lorazepam—Confusional state—Temozolomide—skin cancer	0.00196	0.0024	CcSEcCtD
Lorazepam—Infection—Temozolomide—skin cancer	0.00193	0.00237	CcSEcCtD
Lorazepam—Nausea—Imiquimod—skin cancer	0.00193	0.00236	CcSEcCtD
Lorazepam—Thrombocytopenia—Temozolomide—skin cancer	0.00191	0.00233	CcSEcCtD
Lorazepam—Convulsion—Fluorouracil—skin cancer	0.0019	0.00233	CcSEcCtD
Lorazepam—Feeling abnormal—Bleomycin—skin cancer	0.0019	0.00233	CcSEcCtD
Lorazepam—Agranulocytosis—Docetaxel—skin cancer	0.00189	0.00232	CcSEcCtD
Lorazepam—Fatigue—Dactinomycin—skin cancer	0.00186	0.00227	CcSEcCtD
Lorazepam—Pain—Dactinomycin—skin cancer	0.00184	0.00225	CcSEcCtD
Lorazepam—Confusional state—Fluorouracil—skin cancer	0.00181	0.00221	CcSEcCtD
Lorazepam—Infection—Fluorouracil—skin cancer	0.00178	0.00218	CcSEcCtD
Lorazepam—Feeling abnormal—Dactinomycin—skin cancer	0.00177	0.00217	CcSEcCtD
Lorazepam—Thrombocytopenia—Fluorouracil—skin cancer	0.00176	0.00215	CcSEcCtD
Lorazepam—Visual impairment—Docetaxel—skin cancer	0.00176	0.00215	CcSEcCtD
Lorazepam—Tachycardia—Fluorouracil—skin cancer	0.00175	0.00214	CcSEcCtD
Lorazepam—Somnolence—Temozolomide—skin cancer	0.00173	0.00212	CcSEcCtD
Lorazepam—Hypersensitivity—Bleomycin—skin cancer	0.0017	0.00208	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Temozolomide—skin cancer	0.00168	0.00206	CcSEcCtD
Lorazepam—Fatigue—Temozolomide—skin cancer	0.00168	0.00205	CcSEcCtD
Lorazepam—Hypotension—Fluorouracil—skin cancer	0.00168	0.00205	CcSEcCtD
Lorazepam—Pain—Temozolomide—skin cancer	0.00166	0.00204	CcSEcCtD
Lorazepam—Constipation—Temozolomide—skin cancer	0.00166	0.00204	CcSEcCtD
Lorazepam—Asthenia—Bleomycin—skin cancer	0.00166	0.00203	CcSEcCtD
Lorazepam—Chills—Docetaxel—skin cancer	0.00163	0.002	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—skin cancer	0.00163	0.00199	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—skin cancer	0.00161	0.00197	CcSEcCtD
Lorazepam—Feeling abnormal—Temozolomide—skin cancer	0.0016	0.00196	CcSEcCtD
Lorazepam—Somnolence—Fluorouracil—skin cancer	0.00159	0.00195	CcSEcCtD
Lorazepam—Erythema—Docetaxel—skin cancer	0.00159	0.00194	CcSEcCtD
Lorazepam—Hypersensitivity—Dactinomycin—skin cancer	0.00159	0.00194	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00155	0.00189	CcSEcCtD
Lorazepam—Asthenia—Dactinomycin—skin cancer	0.00154	0.00189	CcSEcCtD
Lorazepam—Pain—Fluorouracil—skin cancer	0.00153	0.00188	CcSEcCtD
Lorazepam—Feeling abnormal—Fluorouracil—skin cancer	0.00148	0.00181	CcSEcCtD
Lorazepam—Vomiting—Bleomycin—skin cancer	0.00147	0.0018	CcSEcCtD
Lorazepam—Rash—Bleomycin—skin cancer	0.00145	0.00178	CcSEcCtD
Lorazepam—Dermatitis—Bleomycin—skin cancer	0.00145	0.00178	CcSEcCtD
Lorazepam—Hypersensitivity—Temozolomide—skin cancer	0.00143	0.00175	CcSEcCtD
Lorazepam—Asthenia—Temozolomide—skin cancer	0.0014	0.00171	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—skin cancer	0.00137	0.00168	CcSEcCtD
Lorazepam—Nausea—Bleomycin—skin cancer	0.00137	0.00168	CcSEcCtD
Lorazepam—Hypertension—Docetaxel—skin cancer	0.00137	0.00168	CcSEcCtD
Lorazepam—Vomiting—Dactinomycin—skin cancer	0.00137	0.00167	CcSEcCtD
Lorazepam—Rash—Dactinomycin—skin cancer	0.00136	0.00166	CcSEcCtD
Lorazepam—Hypersensitivity—Fluorouracil—skin cancer	0.00132	0.00162	CcSEcCtD
Lorazepam—Dry mouth—Docetaxel—skin cancer	0.00132	0.00162	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—skin cancer	0.0013	0.0016	CcSEcCtD
Lorazepam—Dizziness—Temozolomide—skin cancer	0.00129	0.00158	CcSEcCtD
Lorazepam—Infection—Docetaxel—skin cancer	0.00129	0.00157	CcSEcCtD
Lorazepam—Nausea—Dactinomycin—skin cancer	0.00128	0.00156	CcSEcCtD
Lorazepam—Thrombocytopenia—Docetaxel—skin cancer	0.00127	0.00155	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—skin cancer	0.00126	0.00155	CcSEcCtD
Lorazepam—Vomiting—Temozolomide—skin cancer	0.00124	0.00151	CcSEcCtD
Lorazepam—Rash—Temozolomide—skin cancer	0.00123	0.0015	CcSEcCtD
Lorazepam—Dermatitis—Temozolomide—skin cancer	0.00123	0.0015	CcSEcCtD
Lorazepam—Headache—Temozolomide—skin cancer	0.00122	0.00149	CcSEcCtD
Lorazepam—Hypotension—Docetaxel—skin cancer	0.00121	0.00148	CcSEcCtD
Lorazepam—Dizziness—Fluorouracil—skin cancer	0.00119	0.00145	CcSEcCtD
Lorazepam—Nausea—Temozolomide—skin cancer	0.00116	0.00141	CcSEcCtD
Lorazepam—Somnolence—Docetaxel—skin cancer	0.00115	0.00141	CcSEcCtD
Lorazepam—Vomiting—Fluorouracil—skin cancer	0.00114	0.0014	CcSEcCtD
Lorazepam—Rash—Fluorouracil—skin cancer	0.00113	0.00138	CcSEcCtD
Lorazepam—Dermatitis—Fluorouracil—skin cancer	0.00113	0.00138	CcSEcCtD
Lorazepam—Headache—Fluorouracil—skin cancer	0.00112	0.00137	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Docetaxel—skin cancer	0.00112	0.00137	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—skin cancer	0.00112	0.00137	CcSEcCtD
Lorazepam—Constipation—Docetaxel—skin cancer	0.00111	0.00135	CcSEcCtD
Lorazepam—Pain—Docetaxel—skin cancer	0.00111	0.00135	CcSEcCtD
Lorazepam—Feeling abnormal—Docetaxel—skin cancer	0.00107	0.00131	CcSEcCtD
Lorazepam—Nausea—Fluorouracil—skin cancer	0.00107	0.0013	CcSEcCtD
Lorazepam—Hypersensitivity—Docetaxel—skin cancer	0.000954	0.00117	CcSEcCtD
Lorazepam—Asthenia—Docetaxel—skin cancer	0.000929	0.00114	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—skin cancer	0.000856	0.00105	CcSEcCtD
Lorazepam—Vomiting—Docetaxel—skin cancer	0.000823	0.00101	CcSEcCtD
Lorazepam—Rash—Docetaxel—skin cancer	0.000816	0.000999	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—skin cancer	0.000815	0.000998	CcSEcCtD
Lorazepam—Headache—Docetaxel—skin cancer	0.000811	0.000992	CcSEcCtD
Lorazepam—Nausea—Docetaxel—skin cancer	0.000769	0.000941	CcSEcCtD
